Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 550 of 6351
-
Could laughter be the key to a calmer, clearer pregnancy?
Symptom relief By invitation onlyPregnancy is a physiological process during which a number of biological changes occur in a woman's body. This period represents an important turning point in the lives of women, whose reproductive capacity ensures the continuation of generations. While some women perceive pregna…
Sponsor: Agri Ibrahim Cecen University • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
New drug duo aims to shrink lung tumors before surgery
Disease control Not yet recruitingTo evaluate the safety and efficacy of SYS6010 combined with osimertinib as neoadjuvant therapy for patients with resectable EGFR mutation non-squamous non-small cell lung cancer.
Phase 2 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Could a common drug prevent brain damage after a stroke?
Disease control Not yet recruitingThe investigators propose to conduct a multicenter randomized trial to test whether cilostazol reduces the incidence of delayed cerebral ischemia (DCI) following aneurysmal subarachnoid hemorrhage (aSAH) and improves patients' neurological prognosis, while assessing its safety.
Phase 3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New combo therapy may let some rectal cancer patients avoid surgery
Disease control Recruiting nowThis is a single-center, exploratory clinical study for patients with newly diagnosed, high-risk, locally advanced rectal cancer. The study aims to evaluate the effectiveness and safety of a comprehensive pre-surgery (neoadjuvant) treatment strategy. All participants will receiv…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can more frequent speech therapy sessions help children speak clearly faster?
Disease control Recruiting nowAchieving speech that is understandable and acceptable to others is the key outcome in the treatment of phonological speech sound disorders. Therefore, speech therapy provided by a speech-language pathologist is essential. Traditionally, this intervention has been delivered twice…
Sponsor: University Ghent • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Could stem cell vesicles help heal the brain after a stroke?
Disease control Recruiting nowThis is a single-center, randomized, open-label, placebo-controlled, dose-escalation trial. The objective of this research is to evaluate the safety, tolerability, and preliminary efficacy of intravenous administration of human-induced neural stem cell-derived extracellular vesic…
Phase 1 • Sponsor: Wei Wang • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New hope for liver cancer patients: 4-drug combo targets untreatable tumors
Disease control Not yet recruitingThis study is a single arm, single center, open label clinical trial. Recruit 34 subjects who meet the inclusion criteria and receive hepatic artery chemoembolization (TACE) and stereotactic body radiotherapy (SBRT) combined with immune checkpoint inhibitors and donafenib treatme…
Phase 2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Immunotherapy plus chemo shows promise for pancreatic cancer before surgery
Disease control Not yet recruitingClinical Study on the Safety and Efficacy of the efficacy and safety of Adebrelimab combined with chemotherapy for neoadjuvant treatment of resectable pancreatic cancer
Phase 2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New combo aims to tame advanced cervical cancer with fewer side effects
Disease control Not yet recruitingThis study is a prospective, randomized, parallel investigation aimed at evaluating different doses of famitinib malate (20mg, 15mg, or 10mg, once daily, respectively) by analyzing the pharmacokinetics, efficacy, safety, and tolerability of famitinib malate combined with camreliz…
Phase 2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New diabetes drug aims to slow kidney failure in High-Risk patients
Disease control Not yet recruitingThis study aims to investigate the impact of adding Ganagliflozin tablets to the current background therapy on preventing the progression of kidney disease in subjects with type 2 diabetes and chronic kidney disease. The efficacy and safety will be evaluated by comparing the effe…
Phase 4 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New triple attack on rare melanoma shows promise in early trial
Disease control Not yet recruitingThis study is a prospective, multicenter, single arm, open label study aimed at evaluating the efficacy and safety of the combination of Carilizumab, Apatinib Mesylate, and first-line radiotherapy for advanced mucosal melanoma.
Phase 2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New combo therapy aims to fix TSH suppression in thyroid cancer
Disease control Not yet recruitingThe global incidence of Differentiated Thyroid Cancer (DTC) is rising. While surgery followed by TSH suppression is the standard of care, achieving target TSH levels with levothyroxine (L-T4) monotherapy remains challenging, with only 25-70% of intermediate/high-risk patients att…
Phase 3 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New immunotherapy combo aims to shrink lung tumors before surgery
Disease control Not yet recruitingThis study is a prospective, II Phase clinical trial designed to evaluate the efficacy and safety of ivonescimab as monotherapy or in combination with platinum-based chemotherapy in the perioperative treatment of resectable non-small cell lung cancer (NSCLC). Patients are strati…
Phase 2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Radiation boost may extend lives in advanced liver cancer
Disease control Recruiting nowThis prospective, multicenter, phase II randomized controlled trial compares the efficacy and safety of SBRT combined with systemic therapy versus systemic therapy alone in BCLC stage C hepatocellular carcinoma (HCC). The primary objective is to compare overall survival (OS) betw…
Phase 2 • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Could surgery after hormone therapy beat advanced prostate cancer?
Disease control Not yet recruitingThis is a prospective, randomized, open-label, phase II multicenter clinical trial evaluating the efficacy and safety of radical prostatectomy in patients with high-volume metastatic hormone-sensitive prostate cancer (mHSPC) who achieve good response after systemic therapy with a…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New CAR-T therapy targets BAFF-R to fight resistant lymphoma
Disease control Recruiting nowThe aim of this study is to analyze the safety of BAFF-R Chimeric Antigen Receptor T-Cell Injection (BAFF-R CAR-T) in participants with relapsed/refractory BAFF-R-positive B-cell lymphoma and explore the Maximum Tolerated Dose (MTD). The secondary objective of this study is to e…
Phase 1/2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New hope for recurrent endometrial cancer: Rina-S faces off against standard chemo
Disease control Recruiting nowThe purpose of this study is to compare how well Rina-S (GEN1184) works compared to treatment of physician's choice (paclitaxel or doxorubicin) that are considered standard medical care for the treatment of recurrent or progressive endometrial cancer (EC) following prior therapy.…
Phase 3 • Sponsor: Genmab • Aim: Disease control
Last updated Sep 10, 2026 08:00 UTC
-
Can inhaled steroids help newborns breathe easier after meconium aspiration?
Disease control CompletedMeconium aspiration syndrome (MAS) is a major cause of respiratory distress in term and post-term neonates and is associated with significant neonatal morbidity. Inflammatory lung injury plays an important role in the pathophysiology of MAS, suggesting that corticosteroid therapy…
Phase 3 • Sponsor: Khyber Teaching Hospital • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New flu prevention drug faces off against tamiflu in hospital trial
Prevention Recruiting nowThis study aims to evaluate the efficacy of antiviral prophylaxis in preventing in-hospital influenza transmission. We will enroll hospitalized patients with confirmed influenza (index cases) and their uninfected roommates (room contacts). These room contacts will be randomized i…
Phase 3 • Sponsor: Capital Medical University • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
New drug cocktail aims to stop rare liver cancer from coming back
Disease control Not yet recruitingTitle: A Study of Cadonilimab Combined with Capecitabine After Surgery for Mixed Type Liver Cancer This is a phase II clinical trial. The main purpose of this study is to find out if using two drugs together, cadonilimab (an immunotherapy drug) and capecitabine (a chemotherapy d…
Phase 2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC